Neuroanatomical differences between first-episode psychosis patients with and without neurocognitive deficit: A 3-year longitudinal study

Frontiers in Psychiatry

Volumn 4, Issue , 2013, Pages

  Ayesa Arriola, Rosa ^a,b   Roiz Santiáñez, Roberto ^a,b   Pérez Iglesias, Rocío ^a,b,c   Ferro, Adele ^d   Sainz, Jesús ^a   Crespo Facorro, Benedicto ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

Cognitive deficit; First episode psychosis; Neuroanatomical; Neurocognition; Schizophrenia

Indexed keywords

ADULT; ANATOMICAL VARIATION; ARTICLE; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISORDERS OF HIGHER CEREBRAL FUNCTION; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LATERAL BRAIN VENTRICLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROIMAGING; OUTCOME ASSESSMENT; PSYCHOSIS; THALAMUS; WHITE MATTER;

EID: 84977608617     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00134     Document Type: Article

References (51)

1. Gonzalez-Blanch C, CrespoFacorro B, Alvarez-Jimenez M, Rodriguez-Sanchez JM, PelayoTeran JM, Perez-Iglesias R, et al. Cognitive dimensions in firstepisode schizophrenia spectrum disorders. J Psychiatr Res (2007) 41(11):968-77. doi:10.1016/j. jpsychires.2006.08.009
2. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, et al. Neuropsychology of firstepisode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry (2000) 157(4): 549-59. doi:10.1176/appi.ajp.157.4. 549
3. Bora E, Yucel M, Pantelis C. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull (2010) 36(1):36-42. doi:10.1093/schbul/sbp094
4. Roy MA, Lehoux C, Emond C, Laplante L, Bouchard RH, Everett J, et al. A pilot neuropsychological study of Kraepelinian and nonKraepelinian schizophrenia. Schizophr Res (2003) 62(1-2):155-63. doi: 10.1016/S0920-9964(02)00481-4
5. Palmer BW, Heaton RK, Paulsen JS, Kuck J, BraffD, Harris MJ, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology (1997) 11(3): 437-46. doi:10.1037/0894-4105.11. 3.437
6. Ayesa-Arriola R, Perez-Iglesias R, Rodriguez-Sanchez JM, PardoGarcia G, Tabares-Seisdedos R, Ayuso-Mateos JL, et al. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry (2013) 43:23-8. doi:10.1016/j.pnpbp.2012.11.012
7. Crespo-Facorro B, Barbadillo L, Pelayo-Teran JM, RodriguezSanchez JM. Neuropsychological functioning and brain structure in schizophrenia. Int Rev Psychiatry (2007) 19(4):325-36. doi:10.1080/09540260701486647
8. Wright IC, Rabe-Hesketh S, WoodruffPW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry (2000) 157(1):16-25.
9. Haijma SV, Van Haren N, Cahn W, Koolschijn PC, HulshoffPol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull (2013) 39(5):1129-38. doi:10.1093/schbul/sbs118
10. Cahn W, HulshoffPol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, et al. Brain volume changes in firstepisode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 59(11):1002-10. doi:10.1001/archpsyc.59.11.1002
11. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry (2003) 60(6):585-94. doi:10.1001/archpsyc.60.6.585
12. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry (2011) 70(7):672-9. doi:10.1016/j.biopsych.2011.05.017
13. Roiz-Santiáñez R, Ayesa-Arriola R, Tordesillas-Gutiérrez D, OrtizGarcía de la Foz V, Pérez-Iglesias R, Pazos A, et al. Three-year longitudinal population-based volumetric MRI study in first-episode schizophreniaspectrum patients. Psychol Med. Available on CJO (2013). doi:10.1017/S0033291713002365
14. DeLisi LE, HoffAL. Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Res (2005) 138(3):265-8. doi:10.1016/j.pscychresns.2005.02. 005
15. Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Lee CU, McCarley RW, et al. Follow-up MRI study of prefrontal volumes in firstepisode psychotic patients. Schizophr Res (2004) 71(2-3):349-51. doi: 10.1016/j.schres.2004.04.010
16. Zipursky RB, Christensen BK, Mikulis DJ. Stable deficits in gray matter volumes following a first episode of schizophrenia. Schizophr Res (2004) 71(2-3):515-6. doi:10. 1016/j.schres.2004.02.028
17. Schaufelberger MS, Lappin JM, Duran FL, Rosa PG, Uchida RR, Santos LC, et al. Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol Med (2011) 41(8):1677-89. doi:10.1017/S0033291710002163
18. Roiz-Santianez R, Perez-Iglesias R, Ortiz-Garcia de la Foz V, Tordesillas-Gutierrez D, Mata I, Gonzalez-Mandly A, et al. One year longitudinal study of the straight gyrus morphometry in first-episode schizophrenia-spectrum patients. Psychiatry Res (2012) 202(1):80-3. doi:10.1016/j.pscychresns.2011.10. 001
19. Perez-Iglesias R, TordesillasGutierrez D, McGuire PK, Barker GJ, Roiz-Santianez R, Mata I, et al. White matter integrity and cognitive impairment in first-episode psychosis. Am J Psychiatry (2010) 167(4):451-8. doi:10.1176/appi.ajp. 2009.09050716
20. Wexler BE, Zhu H, Bell MD, Nicholls SS, Fulbright RK, Gore JC, et al. Neuropsychological near normality and brain structure abnormality in schizophrenia. Am J Psychiatry (2009) 166(2):189-95. doi:10.1176/appi.ajp.2008.08020258
21. Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla M, MartinezGarcia O, Llorca J, Luis VazquezBarquero J. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry (2006) 67(10):1511-21. doi: 10.4088/JCP.v67n1004
22. Pelayo-Teran JM, Perez-Iglesias R, Ramirez-Bonilla M, GonzalezBlanch C, Martinez-Garcia O, Pardo-Garcia G, et al. Epidemiological factors associated with treated incidence of first-episode nonaffective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Interv Psychiatry (2008) 2(3):178-87. doi:10.1111/j. 1751-7893.2008.00074.x
23. First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Non Patient Edition. New York: New York State Psychiatric Institute (2001).
24. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry (1992) 49(8):615-23. doi:10.1001/archpsyc.1992.01820080023004
25. Rodriguez-Sanchez JM, AyesaArriola R, Perez-Iglesias R, Perianez JA, Martinez-Garcia O, Gomez-Ruiz E, et al. Course of cognitive deficits in first episode of non-affective psychosis: a 3-year follow-up study. Schizophr Res (2013) 150(1):121-8. doi:10.1016/j.schres.2013.06.042
26. Overall JE, Gorman DR. The brief psychiatric rating scale. Psychol Rep (1962) 10:799-821. doi:10.2466/pr0.1962.10.3.799
27. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa (1983).
28. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa (1984).
29. Grube BS, Bilder RM, Goldman RS. Meta-analysis of symptom factors in schizophrenia. Schizophr Res (1998) 31(2-3):113-20. doi:10. 1016/S0920-9964(98)00011-5
30. Rey A. L'examen Clinique en Psychologie. Paris: Presses Universitaires de France (1964).
31. Osterrieth PA. Contribution a l'étude de la perception et de la memoire (The test of copying a complex figure: a contribution to the study of perception and memory). Arch Psychol (1944) 30:286-350.
32. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Therapy and Clinical Interpretation. Tucson, Ariz: Neuropsychological Press (1985).
33. Wechsler D. Weschsler Adult Intelligence Scale-III. San Antonio: The Psychological Corporation (1997).
34. Lezak MD. Neuropsychological Assessment. New York: O. U. Press (1995).
35. Cegalis J, Bowlin J. VIGIL: Software for the Assessment of Attention. Nashua, NH: Forthought (1991).
36. Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2009) 35(5):1022-9. doi:10.1093/schbul/sbn044
37. Keefe RS, Fenton WS. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull (2007) 33(4):912-20. doi:10.1093/schbul/sbm046
38. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D. Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph (2002) 26(4):251-64. doi:10.1016/S0895-6111(02)00011-3
39. Andreasen NC, Rajarethinam R, Cizadlo T, Arndt S, Swayze VW II, Flashman LA, et al. Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr (1996) 20(1):98-106. doi:10.1097/00004728-199601000-00018
40. Harris G, Andreasen NC, Cizadlo T, Bailey JM, Bockholt HJ, Magnotta VA, et al. Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J Comput Assist Tomogr (1999) 23(1):144-54. doi:10.1097/00004728-199901000-00030
41. Magnotta VA, Heckel D, Andreasen NC, Cizadlo T, Corson PW, Ehrhardt JC, et al. Measurement of brain structures with artificial neural networks: two-and three-dimensional applications. Radiology (1999) 211(3):781-90.
42. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, GonzalezBlanch C, Perez-Iglesias R, Gutierrez A, et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr Res (2007) 91(1-3):87-96. doi:10.1016/j.schres.2006. 12.015
43. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, RodriguezSanchez JM, Perez-Iglesias R, Gonzalez-Blanch C, et al. Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. Neuroimage (2007) 35(4):1613-23. doi:10.1016/j. neuroimage.2007.01.048
44. Brans RG, van Haren NE, van Baal GC, Staal WG, Schnack HG, Kahn RS, et al. Longitudinal MRI study in schizophrenia patients and their healthy siblings. Br J Psychiatry (2008) 193(5):422-3. doi:10.1192/bjp.bp.107.041467
45. Ortiz-Gil J, Pomarol-Clotet E, Salvador R, Canales-Rodriguez EJ, Sarro S, Gomar JJ, et al. Neural correlates of cognitive impairment in schizophrenia. Br J Psychiatry (2011) 199(3):202-10. doi:10.1192/bjp.bp.110.083600
46. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry (2011) 70(1): 88-96. doi:10.1016/j.biopsych. 2011.01.032
47. Van Haren NE, Cahn W, HulshoffPol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neurosci Biobehav Rev (2012) (in press). doi:10.1016/j.neubiorev.2012.09.006
48. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. HGDH Study Group. Antipsychotic drug effects on brain morphology in firstepisode psychosis. Arch Gen Psychiatry (2005) 62(4):361-70. doi:10.1001/archpsyc.62.4.361
49. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with firstepisode schizophrenia. Am J Psychiatry (2003) 160(1):156-64. doi:10. 1176/appi.ajp.160.1.156
50. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T, et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry (2007) 62(7): 773-83. doi:10.1016/j.biopsych. 2007.03.030
51. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, PelayoTeran JM, Rodriguez-Sanchez JM, Tordesillas-Gutierrez D, et al. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog Neuropsychopharmacol Biol Psychiatry (2008) 32(8):1936-43. doi:10.1016/j.pnpbp.2008.09.020